Etani H, Kimura K, Isaka Y, Kim B H, Naka M, Kinoshita N, Nukada T, Uzi S, Washitani F, Matsuoka T
Department of Cardiovascular Medicine, Osaka-Minami National Hospital.
Kaku Igaku. 1992 Jun;29(6):651-7.
A dual tracer technique using 111In labeled platelets and 99mTc labeled human serum albumin was applied to evaluate the in vivo thrombogenicity in 12 cases with abdominal aortic aneurysm (AAA) and the effect of antiplatelet drug on the thrombogenicity. The magnitude of platelet accumulation at AAA was expressed as the ratio of radioactivity of 111In platelets on the vascular wall to those in the blood pool (PAI; platelet accumulation index). Of the 12 patients with AAA, 11 had positive studies on baseline imaging and 1 had equivocally positive image. The PAI value (Mean +/- SD) over the AAA was 53.8 +/- 34.1% as compared to -8.6 +/- 4.4% in the control group (p less than 0.01). Seven patients with an AAA and positive baseline images were restudied during platelet active drug with 325 mg of aspirin. During treatment with aspirin, of 7 patients, 5 had positive images, of which 3 were decreased and others unchanged compared to baseline studies, 1 equivocally positive one and one negative one. The PAI value during treatment (21.9 +/- 18.6%) was significantly decreased compared to those in baseline study (52.1 +/- 23.9%). Our results suggest that the method used for platelet imaging in the present study may be useful for studying the in vivo thrombogenicity and the effect of platelet active drugs in AAA.
采用一种双示踪技术,即使用铟 - 111标记的血小板和锝 - 99m标记的人血清白蛋白,来评估12例腹主动脉瘤(AAA)患者的体内血栓形成倾向以及抗血小板药物对血栓形成倾向的影响。腹主动脉瘤处血小板聚集的程度用血管壁上铟 - 111标记血小板的放射性与血池中的放射性之比来表示(PAI;血小板聚集指数)。在12例腹主动脉瘤患者中,11例在基线成像时有阳性结果,1例图像结果不明确。腹主动脉瘤处的PAI值(平均值±标准差)为53.8±34.1%,而对照组为 - 8.6±4.4%(p<0.01)。7例腹主动脉瘤且基线图像为阳性的患者在服用325毫克阿司匹林进行血小板活性药物治疗期间再次进行研究。在阿司匹林治疗期间,7例患者中5例图像为阳性,其中3例与基线研究相比图像降低,其他不变,1例结果不明确,1例为阴性。治疗期间的PAI值(21.9±18.6%)与基线研究时(52.1±23.9%)相比显著降低。我们的结果表明,本研究中用于血小板成像的方法可能有助于研究腹主动脉瘤的体内血栓形成倾向以及血小板活性药物的作用。